Blackstone Inc. and TPG Inc. are reportedly close to finalizing a significant acquisition deal for Hologic Inc. that could exceed $17 billion, including debt. Sources familiar with the negotiations indicated that an announcement might occur within the next few days.
Details of the Acquisition
The discussions currently center around a share price exceeding $75. Following the leak of the negotiations, Hologic’s stock surged approximately 6% in late trading. It had previously closed up 2% at $69.85 in New York, resulting in a market capitalization of around $15.5 billion.
Current Status of Negotiations
- Parties Involved: Blackstone and TPG
- Company Target: Hologic Inc.
- Potential Deal Value: Over $17 billion
- Current Share Price: Discussions over $75
- Recent Stock Increase: 6% jump upon news announcement
- Market Capitalization: Approximately $15.5 billion
Despite the positive developments, a final deal has yet to be reached, and the negotiations may still collapse. Officials from both Blackstone and TPG have opted not to comment on the matter. Furthermore, Hologic’s spokesperson also refrained from providing remarks.
About Hologic
Headquartered in Marlborough, Massachusetts, Hologic focuses on women’s health. The company develops diagnostic solutions targeting breast and cervical cancers, as well as infectious diseases, including COVID-19.
If finalized, this acquisition would stand as one of the largest private equity takeovers globally this year, according to Bloomberg’s compiled data. As the negotiations evolve, further updates are anticipated from El-Balad.
